EULAST is a large international trial comparing Paliperidone and Aripiprazole; two licensed and commonly prescribed antipsychotic medications. We will be investigating treatment efficacy, compliance rates and any potential side-effects, in both oral and depot administration.
Participants are randomised to one of four different treatment groups:
Participants in this study will receive this treatment for a period of 18 months. Participants are asked to visit the research clinic monthly for physical monitoring and mental health assessments.
If you are interested in taking part or would like some more information please contact Jessica True, Clinical Research Coordinator on 019327 222 47 or email@example.com . Alternatively you can contact the Principle Investigator Dr Nilforooshan.